Pfizer-BioNTech COVID-19 Vaccine Safe, Effective in Cancer Patients

TUESDAY, July 13, 2021 -- The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) BNT162b2 vaccine (Pfizer-BioNTech) appears to be safe and achieves satisfactory serologic status in patients with cancer, according to a study published...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news